Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voluven vs Albumin in Liver Transplantation
NCT00308100Phase 4Terminated
- Sponsor
- Fresenius Kabi
- Start
- Oct 2005
- Primary completion
- Jul 2008
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Volulyte in hypovolemia, sponsored by Fresenius Kabi. Started Oct 2005; status: terminated.
02
Drugs
Volulyte
03
Conditions
hypovolemia
Beyond the preview
Go deeper on NCT00308100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00308100.